CTFH latest to partner with Insilico in AI discovery deal

In the latest addition to a growing roster of industry collaborations, AI company Insilico has partnered with CTFH to discover and develop two programs for triple-negative breast cancer.

Insilico Medicine Inc. is eligible to receive up to

Read the full 364 word article

User Sign In